About nutra pharm cp - NPHC
Nutra Pharma Corp. operates as a bio pharmaceutical company. The firm engages in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Boca Raton, FL.
NPHC At a Glance
Nutra Pharma Corp.
6400 Park of Commerce Blvd
Boca Raton, Florida 33487
| Phone | 1-954-509-0911 | Revenue | 392.15K | |
| Industry | Pharmaceuticals: Major | Net Income | -1,285,663.00 | |
| Sector | Health Technology | Employees | 6 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
NPHC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.957 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -13.576 |
| Enterprise Value to Sales | 27.254 |
| Total Debt to Enterprise Value | 0.932 |
NPHC Efficiency
| Revenue/Employee | 65,358.333 |
| Income Per Employee | -214,277.167 |
| Receivables Turnover | 1.436 |
| Total Asset Turnover | 0.633 |
NPHC Liquidity
| Current Ratio | 0.025 |
| Quick Ratio | 0.023 |
| Cash Ratio | 0.004 |
NPHC Profitability
| Gross Margin | 63.068 |
| Operating Margin | -224.001 |
| Pretax Margin | -327.85 |
| Net Margin | -327.85 |
| Return on Assets | -207.383 |
| Return on Equity | N/A |
| Return on Total Capital | 26.533 |
| Return on Invested Capital | N/A |
NPHC Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -205.60 |
| Total Debt to Total Assets | 1,661.797 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -2.894 |